Anu Mustila

Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis. A marker of severe disease with associated nephropathy

Anu Mustila, Markku Korpel, Jukka Mustonen et al. · Arthritis & Rheumatism · 1997 · 73 citations

Medicine, Nephrology, Pathology +17

Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: An early marker of progressive erosive disease

Anu Mustila, Leena Paimela, Marjatta Leirisalo‐Repo et al. · Arthritis & Rheumatism · 2000 · 51 citations

Life Sciences, Immunology, Pathology +17

The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.

Susanna Sihvonen, Markku Korpela, Anu Mustila et al. · PubMed · 2005 · 50 citations

Life Sciences, Immunology, Internal Medicine +17

Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.

Anu Mustila, Markku Korpela, A-M Haapala et al. · PubMed · 2011 · 36 citations

Medicine, Internal Medicine, Pharmacotherapy +17